The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the rival medicines.

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those ... Now, he’s a Mets’ batting practice pitcher. NewsdayTV’s Carissa Kellman reports. Credit: Newsday/Kendall Rodriguez; Photo credit: Joseph D.

A new study has found that people taking Eli Lilly’s obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk’s Wegovy. The study — published May 11 in the New England Journal of Medicine — followed 751 people across the U.